R3 Vascular is an early-stage medical device company that manufactures bioresorbable vascular scaffolds (BVS) for the treatment of peripheral artery diseases. Their technology, which includes a sirolimus coating with anti-inflammatory properties, provides the strength of metallic stents during the artery remodeling process following interventional procedures. Unlike permanent implants, R3 Vascular's BVS are fully bioresorbable, eliminating the limitations associated with long-term implantation. Their focus is on treating peripheral arterial disease below the knee, offering organizations an innovative solution to modernize patient care.